Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rene Opavsky

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Epigenomes|August 27, 2024
Genome-Wide Methylation Profiling of Peripheral T-Cell Lymphomas Identifies TRIP13 as a Critical Driver of Tumor Proliferation and SurvivalPawel Nowialis, Julian Tobon, Katarina Lopusna, et al.
Molecular Medicine (Cambridge, Mass.)|May 8, 2014
Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive diseaseAmit K Mittal, Nagendra K Chaturvedi, Karan J Rai, et al.
Cell Reports|May 3, 2016
Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3aStaci L Haney, G Michael Upchurch, Jana Opavska, et al.
Plos Genetics|October 3, 2007
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cellsRene Opavsky, Shu-Huei Wang, Prashant Trikha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2007
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesisRene Opavsky, Shih-Yin Tsai, Martin Guimond, et al.
Nature|July 3, 2008
Mouse development with a single E2F activatorShih-Yin Tsai, Rene Opavsky, Nidhi Sharma, et al.
Genomics|October 12, 2004
A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignanciesLi Yu, Chunhui Liu, Kristi Bennett, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2014
Immature truncated O-glycophenotype of cancer directly induces oncogenic featuresPrakash Radhakrishnan, Sally Dabelsteen, Frey Brus Madsen, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Epigenomes|August 27, 2024
Genome-Wide Methylation Profiling of Peripheral T-Cell Lymphomas Identifies TRIP13 as a Critical Driver of Tumor Proliferation and SurvivalPawel Nowialis, Julian Tobon, Katarina Lopusna, et al.
Molecular Medicine (Cambridge, Mass.)|May 8, 2014
Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive diseaseAmit K Mittal, Nagendra K Chaturvedi, Karan J Rai, et al.
Cell Reports|May 3, 2016
Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3aStaci L Haney, G Michael Upchurch, Jana Opavska, et al.
Plos Genetics|October 3, 2007
CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cellsRene Opavsky, Shu-Huei Wang, Prashant Trikha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2007
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesisRene Opavsky, Shih-Yin Tsai, Martin Guimond, et al.
Nature|July 3, 2008
Mouse development with a single E2F activatorShih-Yin Tsai, Rene Opavsky, Nidhi Sharma, et al.
Genomics|October 12, 2004
A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignanciesLi Yu, Chunhui Liu, Kristi Bennett, et al.
Cancer Research|March 8, 2013
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancerWan-chi Lin, Nirakar Rajbhandari, Chengbao Liu, et al.
The Journal of Clinical Investigation|December 3, 2011
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesisRyan A Hlady, Slavomira Novakova, Jana Opavska, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2014
Immature truncated O-glycophenotype of cancer directly induces oncogenic featuresPrakash Radhakrishnan, Sally Dabelsteen, Frey Brus Madsen, et al.
Pageof 4